NCT06470100View on ClinicalTrials.gov

Dexamethasone Vs. Dexmedetomidine for ESPB in Pain Management After Knee Arthroplasty

PHASE4RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 13, 2024

Primary Completion Date

July 30, 2025

Study Completion Date

September 30, 2025

Conditions
Knee OsteoarthritisKnee ArthritisKnee DiseaseKnee Pain Chronic
Interventions
DRUG

0.9% Sodium Chloride Injection

unilateral administration of 20ml of 0,2% ropivacaine + 2ml 0.9% sodium chloride for the erector spine plane block

DRUG

Dexamethasone

unilateral administration of 20ml of 0,2% ropivacaine with 4mg Dexamethasone for the erector spine plane block

DRUG

Dexmedetomidine

unilateral administration of 20ml of 0,2% ropivacaine with 50ug Dexmedetomidine for the erector spine plane block

Trial Locations (1)

61-701

RECRUITING

Poznan University of Medical Sciences, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER

NCT06470100 - Dexamethasone Vs. Dexmedetomidine for ESPB in Pain Management After Knee Arthroplasty | Biotech Hunter | Biotech Hunter